Metabolism of small antimicrobial β2,2-amino acid derivatives by murine liver microsomes
Tóm tắt
We have investigated the in vitro metabolism of three small antimicrobial β2,2-amino acid derivatives (M
w < 500) that are highly potent against methicillin resistant Staphylococcus aureus, and are among the first compounds designed from small cationic antimicrobial peptides with potential for oral administration. The β2,2-amino acid derivatives are virtually completely resistant against degradation by proteases, and to further explore their drug potential, we have investigated the hepatic Phase I metabolism of this class of antimicrobial compounds. The β2,2-amino acid derivatives were incubated with murine liver microsomes and the metabolites analyzed semi-quantitatively by HPLC–MS and qualitatively by ultra performance liquid chromatography coupled to a tandem mass spectrometer which enabled identification of the metabolites by careful interpretation of the collision activated dissociation spectra. The study shows that sterically hindered β2,2-amino acid derivatives that otherwise are stable against proteolytic degradation underwent Phase I metabolism and were oxidized to a number of different metabolites depending on the structure of the β2,2-amino acid side-chains.
Tài liệu tham khảo
Ackley DC, Rockich KT, Baker TR (2004) Metabolic stability assessed by liver microsomes and hepatocytes. In: Yan Z, Caldwell GW (eds) Optimization in drug discovery: in vitro methods. Humana Press, NJ, pp 151–162
Boman HG (1995) Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 13:61–92
Boman HG (2003) Antibacterial peptides: basic facts and emerging concepts. J Intern Med 254(3):197–215
Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J (2009) Bad bugs, no drugs: No ESKAPE! An update from the infectious diseases society of America. Clin Infect Dis 48(1):1–12
Cho TM, Rose RL, Hodgson E (2006) In vitro metabolism of naphthalene by human liver microsomal cytochrome P450 enzymes. Drug Metab Dispos 34(1):176–183
Corey GR, Stryjewski ME, Weyenberg W, Yasothan U, Kirkpatrick P (2009) Telavancin. Nat Rev Drug Discov 8(12):929–930
Gimenez D, Andreu C, del Olmo M-l, Varea T, Diaz D, Asensio G et al (2006) The introduction of fluorine atoms or trifluoromethyl groups in short cationic peptides enhances their antimicrobial activity. Bioorg Med Chem 14(20):6971–6978
Hagmann WK (2008) The many roles for fluorine in medicinal chemistry. J Med Chem 51(15):4359–4369
Hancock RE, Lehrer R (1998) Cationic peptides: a new source of antibiotics. Trends Biotechnol 16(2):82–88
Hansen T, Alst T, Havelkova M, Strøm MB (2010) Antimicrobial activity of small β-peptidomimetics based on the pharmacophore model of short cationic antimicrobial peptides. J Med Chem 53(2):595–606
Hansen T, Ausbacher D, Flaten GE, Havelkova M, Strøm MB (2011) Synthesis of cationic antimicrobial β2,2-amino acid derivatives with potential for oral administration. J Med Chem 54(3):858–868
Haug BE, Skar ML, Svendsen JS (2001) Bulky aromatic amino acids increase the antibacterial activity of 15-residue bovine lactoferricin derivatives. J Pept Sci 7(8):425–432
Haug BE, Stensen W, Stiberg T, Svendsen JS (2004) Bulky nonproteinogenic amino acids permit the design of very small and effective cationic antibacterial peptides. J Med Chem 47(17):4159–4162
IDSA (2004) Bad bugs, no drugs. Infectious Diseases Society of America
Kirk KL (2006) Fluorine in medicinal chemistry: recent therapeutic applications of fluorinated small molecules. J Fluorine Chem 127(8):1013–1029
Li C, Haug T, Moe MK, Styrvold OB, Stensvag K (2010) Centrocins: isolation and characterization of novel dimeric antimicrobial peptides from the green sea urchin. Strongylocentrotus droebachiensi. Dev Comp Immunol 34(9):959–968
Livermore DM (2009) Has the era of untreatable infections arrived? J Antimicrob Chemother 64(Suppl 1):i29–i36
Mills RF, Adams SS, Cliffe EE, Dickinson W, Nicholson JS (1973) The metabolism of ibuprofen. Xenobiotica 3(9):589–598
Moe MK, Strøm MB, Jensen E, Claeys M (2004) Negative electrospray ionization low-energy tandem mass spectrometry of hydroxylated fatty acids: a mechanistic study. Rapid Commun Mass Spectrom 18(15):1731–1740
Neu HC (1992) The crisis in antibiotic resistance. Science 257(5073):1064–1073
Norrby SR, Nord CE, Finch R (2005) Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis 5(2):115–119
Opar A (2007) Bad bugs need more drugs. Nat Rev Drug Discov 6(12):943–944
Park K, kitteringham NR, O′Neill PM (2001) Metabolism of fluorine-containing drugs. Annu Rev Pharmacol 41:443–470
Paterson JW, Conolly ME, Dollery CT, Hayes A, Cooper RG (1970) The pharmacodynamics and metabolism of propranolol in man. Eur J Clin Pharmacol 2(3):127–133
Peet NP (2010) Drug resistance: a growing problem. Drug Discov Today 15(15–16):583–586
Samuelsen O, Haukland HH, Jenssen H, Kramer M, Sandvik K, Ulvatne H, Vorland LH (2005) Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus. FEBS Lett 579(16):3421–3426
Strøm MB, Haug BE, Skar ML, Stensen W, Stiberg T, Svendsen JS (2003) The pharmacophore of short cationic antibacterial peptides. J Med Chem 46(9):1567–1570
Svenson J, Stensen W, Brandsdal B, Olav, Haug BE, Monrad J, Svendsen JS et al (2008) Antimicrobial peptides with stability toward tryptic degradation. Biochemistry 47(12):3777–3788
Tew GN, Clements D, Tang H, Arnt L, Scott RW (2006) Antimicrobial activity of an abiotic host defense peptide mimic. Biochim Biophys Acta-Biomemb 1758(9):1387–1392
Tew GN, Scott RW, Klein ML, DeGrado WF (2010) De novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications. Acc Chem Res 43(1):30–39
Tindell GL, Walle T, Gaffney TE (1972) Rat liver microsomal metabolism of propranolol: identification of seven metabolites by gas chromatography-mass spectrometry. Life Sci 11((21, Part 2)):1029–1036
Tørfoss V, Ausbacher D, Cavalcanti-Jacobsen CD, Hansen T, Brandsdal BO, Havelkova M, Strøm MB (2012) Synthesis of anticancer heptapeptides containing a unique lipophilic beta(2,2) -amino acid building block. J Pept Sci. doi: 10.1002/psc.1434
Vasskog T, Berger U, Samuelsen PJ, Kallenborn R, Jensen E (2006) Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromso Norway. J Chromatogr A 1115(1–2):187–195